Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 1;26(1):e43-e48.
doi: 10.4317/medoral.23940.

Periodontitis and Alzheimer´s disease

Affiliations
Review

Periodontitis and Alzheimer´s disease

D- Sansores-España et al. Med Oral Patol Oral Cir Bucal. .

Abstract

Background: Alzheimer's disease (AD), the main cause of dementia in the adult population, is characterized by a progressive loss of cognitive function. It is considered that neuroinflammation plays a fundamental role in its onset and progression. The bacteria present in the disbiotic microbiome generated during the course of periodontitis (PE) are capable of inducing a systemic inflammatory response, exacerbating the production of proinflammatory mediators that have the potential to spread to the systemic circulation.

Material and methods: A literature review was made using the databases Scielo, PubMed, EBSCO and key words "Alzheimer disease", "Periodontitis", "Neurodegeneration", "Inflammation mediators", "Elderly".

Results: Several hypotheses point to similar pathophysiological pathways in the establishment of AD and PE, sharing cellular and molecular proinflammatory characteristics. In periodontitis, locally produced cytokines and pro-inflammatory products spread from the ulcerated periodontal pocket into the systemic circulation, or around the trigeminal nerve terminals, which allows the passage of bacteria or their products to the brain. This fact leads to the formation of plaques of amyloid peptide and intraneuronal neurofibrillar tangles (NFTs) that activate the glial cells producing a significant increase in proinflammatory cytokines in the affected regions that lead to a loss of neuronal synapses and neurodegeneration, contributing to the progression of AD.

Conclusions: This review of the literature contributes to the understanding of the pathological pathways shared by both diseases such as oxidative damage and inflammation. There is not enough evidence to determine an association between this two pathologies, so it is considered necessary to conduct studies for determine if periodontitis is capable of inducing or exacerbating the neuroinflammation that will trigger AD.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The authors declare that in this study there are not conflicts of interests.

Figures

Figure 1
Figure 1
Common pathophysiological pathways between AD and periodontitis. The increase in inflammatory activity is the point of confluence between AD and periodontitis. As a result of the activity of periodontopathogens on the one hand and microglial activation on the other, an increase in the levels of the main proinflammatory molecules and their metabolites is produced, when this state is maintained in the long term it generates tissue destruction.
Figure 2
Figure 2
Neuroinflammatory hypotesis in the establishment of AD. When the inflammatory state is persistent, microglia and astrocytes modify their phenotype to reactive cells, increasing the secretion of pro-inflammatory cytokines and generating a metabolic, energetic and oxidative imbalance in the neuron that will respond by increasing the production of Aβ and the hyperphosphorylation of the microtubule-associated protein, Tau, events that generate neuro and synaptotoxicity.
Figure 3
Figure 3
Inflammatory response of brain cells to oral bacteria. Model that suggests that periodontal bacteria and their products can invade the brain via and possibly generate a local inflammatory response and neurotoxicity.

References

    1. Knopman DS, De-Kosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N. Practice parameter: Diagnosis of dementia (anevidence-based review). Report of the Quality Standards Sub-committee of the American Academy of Neurology. Neurology. 2001;56:1143–53. - PubMed
    1. Calsolaro V, Antognoli R, Okoye C, Monzani F. The use of antipsychotic drugs for treating behavioral symptoms in Alzheimer's disease. Frontiers in Pharmacology. 2019;10:1–8. - PMC - PubMed
    1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–7. - PMC - PubMed
    1. Kamer AR, Craig RG, Dasanayake AP, Brys M, Glodsik-Sobranzka L, De-Leon MJ. Inflammation and Alzheimer's disease: Possible role of periodontal diseases. Alzheimers Dement. 2008;4:242–50. - PubMed
    1. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC. Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367:795–804. - PMC - PubMed